封面
市场调查报告书
商品编码
1983211

眼内植入市场:依植入类型、应用和地区划分

Ocular Implant Market, By Implant Type, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到2026年,眼内植入市场规模将达203.75亿美元,2033年将达到330.2亿美元。预计从2026年到2033年,该市场将以7.3%的复合年增长率成长。

报告范围 报告详情
基准年: 2025 2026年市场规模: 203.75亿美元
历史数据时期: 2020年至2024年 预测期: 2026年至2033年
2026年至2033年预测期间的复合年增长率: 7.30% 2033年市场规模预测: 330.2亿美元

人工水晶体是用来取代人眼天然水晶体的人工装置。它是治疗白内障手术的一部分。每隻眼睛在瞳孔后方都有一个透明的、由蛋白质构成的“晶状体”,其中充满液体。水晶体将光线聚焦到视网膜上,视网膜再将光线传递到大脑。人工植入是一种颅面假体,用于取代因眼球摘除、眼球切除或眼眶切除而缺失的天然眼球。人工植入有多种形状,包括球形、椭圆形、现成型和客製化型。一般来说,植入可分为两大类:非整合型(无孔)和整合型(有孔)。人工植入有助于改善眼部缺陷或失明患者的外观。人工植入又称为玻璃体眼或义眼。白内障是导致失明的主要原因之一,尤其是在老年人身上。然而,这些问题可以透过手术矫正,美国每年进行超过200万例此类手术。人工水晶体(IOL)由透明塑胶製成,大小约为10美分硬币的三分之一。目前有多种类型可供选择。

  • 单焦点人工水晶体:这是最常见的一种。与人体内可伸缩弯曲以聚焦的天然水晶体不同,这种植入始终聚焦于一个固定距离。如果患者需要看清远处的物体,则需要使用单焦点人工水晶体。
  • 多焦点人工水晶体:类似眼镜中的双焦点和渐进多焦点镜片,这种晶体具有可以改善不同距离视力的区域。大脑可能需要几个月的时间来适应,视力才会感觉自然。此外,与单焦点晶体相比,更容易出现光晕和光源周围的眩光。
  • 可调式人工水晶体:此柔性水晶体的功能与人眼水晶体类似,可调整焦距,进而降低配戴老花眼镜的可能性。
  • 散光矫正型人工水晶体:这种水晶体适用于患有散光或角膜形状偏椭圆而非圆形的情况。散光不仅会导致近视和远视模糊,还会影响整体视力。由于这种水晶体可以矫正散光,因此术后您可能无需配戴眼镜来矫正散光。

市场动态

眼内植入产品数量的不断增长,预计将推动全球眼内植入市场的成长。这些产品广泛应用于眼科手术,用于矫正眼部畸形。例如,2019年2月,製药公司EyePoint Pharmaceuticals, Inc.在美国推出了「YUTIQ」。 YUTIQ是一种有效期为3年的玻璃体内植入,用于治疗涉及眼后部的慢性非感染性葡萄膜炎。本产品于2018年10月获得美国食品药物管理局(FDA)的核准。

此外,眼部功能障碍和疾病的日益普遍预计将推动全球人工眼内植入市场的成长。例如,根据青光眼研究基金会的数据,截至2019年1月,美国已有超过300万人被诊断出患有青光眼。美国国家眼科研究所预测,到2030年,这数字将成长58%,达到420万人。

本报告的主要特点

  • 本报告指出了各个细分市场的潜在商机,并概述了该市场中一系列有吸引力的投资提案。
  • 此外,它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
  • 本节根据以下参数介绍全球眼内植入市场的主要企业:公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
  • 《全球眼内植入市场》报告面向该行业的众多相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过分析全球眼内植入市场中使用的各种策略矩阵来促进决策。

目录

第一章:分析目标与假设

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章:市场动态、监管与趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 技术进步
  • 历史沿革
  • 企业合併(M&A)
  • 法规环境
  • 波特五力分析
  • PEST分析

第四章:全球眼内植入市场:依植入类型划分(2026-2033 年)

  • 概述
  • 人工水晶体(IOL)
  • 非球面人工水晶体
  • 散光人工水晶体
  • 多焦点人工水晶体
  • 前房型人工水晶体
  • 其他的
  • 角膜植入
  • 青光眼植入
  • 眼眶植入
  • 人工眼
  • 其他的

第五章:全球眼内植入市场:依应用领域划分(2026-2033年)

  • 概述
  • 青光眼手术
  • 眼部整形手术
  • 药物输送
  • 老龄化黄斑部病变(AMD)
  • 美容目的
  • 其他的

第六章 全球眼内植入市场:按地区划分(2026-2033 年)

  • 北美洲
    • 我们
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韩国
    • 其他亚太地区
  • 中东
    • GCC
    • 以色列
    • 其他中东国家
  • 非洲
    • 北非
    • 中非
    • 南非

第七章 竞争情势

  • 热图分析
  • 公司简介
    • Alcon(Novartis AG)
    • Pfizer Inc.
    • STAAR Surgical
    • Johnson &Johnson Services
    • MORCHER GmbH
    • Bausch &Lomb Incorporated.
    • Carl Zeiss
    • OSD Medical GmbH,
    • Ophtec BV

第八章

  • 参考
  • 分析方法
简介目录
Product Code: CMI2699

Ocular Implant Market is estimated to be valued at USD 20,375 Mn in 2026 and is expected to reach USD 33,020 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 20,375 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.30% 2033 Value Projection: USD 33,020 Mn

An intraocular lens implant is an artificial replacement for the lens of individual person's eye. It is part of the surgery to fix cataracts. Each eye has a lens, a window made of clear protein, and water that sits behind the pupil. The lens focuses light onto the retina, which sends it to your brain. Ocular implants are type of craniofacial prosthesis that replace an absent natural eye, following an enucleation, evisceration, or orbital exenteration. There are different types of ocular implants ranging from shape such as spherical and oval, stock, and custom. The basic simplification of implants can be to divide them into two main groups: non-integrated (non-porous) and integrated (porous). Ocular implant help to improve the appearance of people with defective eye or with lost eye. Ocular implants are also called as glass eye or artificial eye. Cataracts are a leading cause of blindness, especially in older people. But they can be corrected through surgery a procedure that is done more than 2 million times a year in the U.S. An intraocular lens implant, or IOL, is made of a clear plastic, and it is about a third the size of a dime. There are several different types.

  • Monofocal IOL: This is the most common. Unlike a person's natural lens, which can stretch or bend to help your eye focus, this implant stays focused at one fixed distance. If a person focuses at a distance.
  • Multifocal implant: Like glasses with bifocal or progressive lenses, this lens has areas that help a person see things at different distances. It could take several months for a person's brain to adapt so that a person's vision seems natural. It can sometimes cause more halos or glare around lights than a monofocal lens.
  • Accommodating IOL: This flexible option acts more like humans natural lens and focuses at more than one distance. It makes an individual less likely to need reading glasses.
  • Toric IOL: The person will get this if person have astigmatism, or a cornea that's more football-shaped than round. This can make vision blurry all over, not just close up or far away. This lens lessens astigmatism so person won't need glasses to correct it after any individual person surgery.

Market Dynamics

Increasing product launches of different types of ocular implants that are widely used in ophthalmic surgery to correct ophthalmic deformities are expected to drive the global ocular implant market growth. For instance, in February 2019, EyePoint Pharmaceuticals, Inc., Pharmaceutical company launched its YUTIQ in the U.S. YUTIQ is three-year intravitreal micro-insert for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The product was approved by U.S. Food and Drug Administration in October 2018.

Moreover, increasing prevalence of ocular dysfunction and disorder is expected to drive growth of the global ocular implant market. For instance, in January 2019, according to Glaucoma research foundation, there were over 3 million people in the U.S. that had been diagnosed with glaucoma. The National Eye Institute projects that this number will be increased by 58% and is expected to reach 4.2 million by 2030.

Key features of the study

  • This report provides an in-depth analysis of the global ocular implant market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global ocular implant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Staar Surgical, Johnson & Johnson Services, Inc., Bausch & Lomb Incorporated., Morcher GmbH, OSD Medical GmbH, Ophtec BV, and ZEISS International
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global ocular implant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ocular implant market

Market Segmentation

  • Implant Type Insights (Revenue, USD Mn, 2026 - 2033)
    • Intraocular Lenses (IOL)
    • Aspheric IOLs
    • Toric IOLs
    • Multifocal IOLs
    • Anterior chamber IOLs
    • Others
    • Corneal Implants
    • Glaucoma Implants
    • Orbital Implants
    • Ocular prosthesis
    • Others
  • Application Insights (Revenue, USD Mn, 2026 - 2033)
    • Glaucoma Surgery
    • Oculoplasty
    • Drug Delivery
    • Age-Related Macular Degeneration (AMD)
    • Aesthetic purpose
    • Others
  • Regional Insights (Revenue, USD Mn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Novartis AG
    • Pfizer Inc.
    • Staar Surgical
    • Johnson & Johnson Services, Inc.
    • Bausch & Lomb Incorporated.
    • Morcher GmbH
    • OSD Medical GmbH
    • Ophtec BV
    • ZEISS International

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Implant Type
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technology Advancements
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Ocular Implant Market, By Implant Type, 2026-2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Intraocular Lenses (IOL)
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Aspheric IOLs
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Toric IOLs
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Multifocal IOL
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Anterior chamber IOL
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Corneal Implants
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Glaucoma Implants
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Orbital Implants
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Ocular prosthesis
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

5. Global Ocular Implant Market, By Application, 2026-2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Glaucoma Surgery
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Oculoplasty
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Drug Delivery
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Age-Related Macular Degeneration (AMD)
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Aesthetic purpose
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

6. Global Ocular Implant Market, By Region, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • North America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Alcon (Novartis AG)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • STAAR Surgical
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Johnson & Johnson Services
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • MORCHER GmbH
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Bausch & Lomb Incorporated.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Carl Zeiss
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • OSD Medical GmbH,
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Ophtec BV
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
      • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact